Updated diagnostic criteria and staging system for multiple myeloma. No myeloma defining events smoldering myeloma m protein. Learn more about the symptoms, causes, diagnosis, risk factors, and treatment of multiple myeloma. Learn about risk factors for this disease, recent updates to the diagnostic criteria, and the treatment options available. The calculator for multiple myeloma diagnostic criteria uses parameters to make a diagnosis.
International myeloma working group updated criteria for the diagnosis of multiple myeloma. Nonchemotherapy agents are replacing the use of conventional chemotherapy. Imwg criteria for the diagnosis of myeloma and guidelines for the diagnostic workup of myeloma criteria for a diagnosis of myeloma followed by the examinations, tests, and imaging studies that are recommended by the working group for the diagnosis of myeloma and related organ dysfunction. International myeloma working group updated criteria for.
Amyloidosis should be suspected in the presence of. In 2014, the international myeloma working group imwg revised the diagnostic criteria for mm. Multiple myeloma symptoms side effects complications. Multiple myeloma diagnosis diagnosis of multiple myeloma. Second, multiple myeloma cells secrete substances that interfere with the normal process of bone repair and growth. The diagnosis of multiple myeloma requires the presence of one or more myeloma defining events mde in addition to evidence of. Criteria for the classification monoclonal gammopathies, multiple myeloma and related disorders. International uniform response criteria for multiple myeloma. Multiple myeloma is a hematologic malignancy characterized by the clonal proliferation of plasma cells in the bone marrow and, usually, the presence of a monoclonal ig in the blood andor urine.
There has been remarkable progress made in the diagnosis and treatment of multiple myeloma mm. Pdf multiple myeloma mm is a plasma cell dyscrasia that accounts for. Multiple myeloma is characterized by uninhibited proliferation of clonal plasma cells. The statistical features, symptomatology, diagnostic criteria and efficacy of the several modes of therapy of multiple myeloma are discussed. Younger patients are candidates for highdose chemotherapy and autologous transplantation strategies. In november 2014, the international myeloma working group imwg updated the criteria for the diagnosis of multiple myeloma to include novel validated biomarkers to better encompass the extent of disease. Multiple myeloma 2016 boca raton regional hospital.
The symptoms of mm are primarily related to bone infiltration by. These new criteria add myeloma defining events, the presence of any one of which is sufficient to diagnose multiple myeloma. Multiple myeloma is the second most common type of blood cancer after leukemia. Table 1, below, outlines the revised imwg criteria for the diagnosis of myeloma. The imwg updated the disease definition of multiple myeloma in 2014 to. It is the second most commonly diagnosed hematologic malignancy with an annual incidence and prevalence in the united states of approximately 15,000 and approximately. Multiple myeloma is the secondmost prevalent blood cancer 10% after nonhodgkins lymphoma. Prior to the 2014 imwg diagnostic criteria, the clinical paradigm for plasma cell dyscrasia without endorgan damage used to be watch and. International myeloma working group imwg updated criteria for. This international myeloma working group consensus updates the disease definition of multiple myeloma to include validated biomarkers in addition to existing requirements of attributable crab features hypercalcaemia, renal failure, anaemia, and bone. In 2005, the first guidelines for the diagnosis and management of multiple myeloma mm were published by the guidelines. The revised international myeloma working group criteria for the diagnosis of multiple myeloma and related disorders are shown on table 1.
The imf s reach extends to more than 525,000 members in 140 countries worldwide. Multiple myeloma is defined as an incurable, complex, and rare malignant disease of the plasma cells. The guideline has been split into 2 documents, focussing on the diagnosis and management of multiple myeloma and supportive care in multiple myeloma 2011 snowden et al 2011. Monitor for multiple myeloma symptoms and m protein serum and urine every six to 12 months.
Monoclonal protein in serum or urine unless nonsecretory. The international myeloma working group recommends the implementation of these criteria in routine practice and in future clinical trials, and recommends that future studies analyse any diff erences in outcome that might occur as a result of the new disease defi nition. Revised international myeloma working group imwg criteria for the diagnosis of multiple myeloma both of the following criteria must be met. If multiple myeloma is suspected, youll be referred to hospital to see a haematologist a doctor who specialises in conditions affecting the blood for further tests and scans. The international myeloma working group imwg revised the disease definition of mm for early diagnosis before endorgan damage occurred. The diagnostic criteria for smoldering asymptomatic multiple myeloma is a serum m protein level of 3 g per dl 30 g per l or more, 10 percent or more bone marrow plasma cells. The imf is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure through. Less than 3 gramsdeciliter gdl of mprotein in the serum the liquid part of the blood. The diagnosis of active multiple myeloma requires the presence of endorgan damage. New diagnostic criteria for myeloma nssg haematology. The terminology of symptomatic and asymptomatic multiple myeloma is increasingly confusing given that more patients without overt symptoms are going to be recommended to start on treatment based on the presence of a biomarker. Updated diagnostic criteria and staging system for. Pdf international myeloma working group updated criteria.
Work up of plasma cell disorders involves establishing the presence of a monoclonal. Multiple myeloma accounts for around 1% of all cancers worldwide and 1015% of all hematological neoplasms. These current guidelines represent a major revision. International myeloma working group updated criteria for the diagnosis of multiple myeloma previous article efficacy and safety of radium223 dichloride in patients with castrationresistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use. The factors that help doctors evaluate and diagnose a disease are known as diagnostic criteria. The imfs library of more than 100 publications, for patients and caregivers as well. Multiple myeloma the path to diagnosis mymyelomateam. Multiple myeloma is diagnosed based on the results of clinical tests.
In 2014, the international myeloma working group imwg panel consensus 1 updated 2003 criteria for the diagnosis of multiple myeloma by adding three new biomarkers, along with a few other modifications. Some early cancers may have signs and symptoms that can be noticed, but that is not always the case. In 2006 guidelines for the diagnosis and management of multiple myeloma were published smith et al, 2006. The international myeloma working group imwg has updated the criteria for diagnosing multiple myeloma and published the new criteria in the lancet oncology. Learn about multiple myeloma symptoms, diagnosis, risk factors, and treatment. Diagnosis is made on serum and urine protein electrophoresis, bone marrow examination, and skeletal survey.
Results of the randomized phase iii trial swog s0777 brian g. The most common medical problems caused by myeloma are called the crab criteria, defined as. Imwg criteria for the diagnosis of myeloma and guidelines. First, multiple myeloma cells gather to form masses in the bone marrow that may disrupt the normal structure of the surrounding bone. A combination of these symptoms, particularly if unexpected or unexplained, should prompt diagnostic evaluation for myeloma. Multiple myeloma early detection, diagnosis, and staging 1. Multiple myeloma mm is a debilitating malignancy that is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance mgus to plasma cell leukemia. Multiple myeloma approximately 30,000 new cases second most frequent hematologic malignancy after nhl accounts for 1015% of hematologic cancers survival 46 years. Our group, which includes more than 180 myeloma researchers worldwide, has updated the definition of multiple myeloma for diagnostic purposes to include validated biomarkers in addition to the current. The above mm diagnostic criteria was created by durie and salmon in 1975, after a study in which the presenting clinical features of 71 patients with multiple myeloma were correlated with myeloma cell mass myeloma cells x 10 12 m 2 of body surface area. The book is made up of 12 chapters of varying lengths and a well written final chapter which is actually a summary of the outstanding points of the preceding sections. Theses recommendations are excerpted from palumbo a et al. These patients typically fulfill the diagnostic criteria for multiple myeloma and have evidence of amyloid light chain deposition confirmed by congo red staining.
Multiple myeloma early detection, diagnosis, and staging. The information in this document does not replace a medical consultation. First described in 1848, mm is characterized by a proliferation of malignant plasma cells and a subsequent overabundance of monoclonal paraprotein m protein. Signs and symptoms of multiple myeloma tests to find multiple myeloma stages and outlook prognosis after a cancer diagnosis, staging provides important information about the extent of cancer in the body and anticipated response to treatment. The diagnosis of mm requires 10% or more clonal plasma cells on bone marrow examination or a biopsyproven plasmacytoma plus the presence of one or more.
Dec 05, 2015 in 2014, the international myeloma working group imwg revised the diagnostic criteria for mm. Fewer than 10% monoclonal plasma cells in the bone marrow. Updated international myeloma working group criteria. Multiple myeloma is often diagnosed based on tests, the patients symptoms and the doctors physical exam of the patient. The patient is not undergoing induction chemotherapy or patient. Multiple myeloma is the third most common hematologic malignancy in the united states. International myeloma working group guidelines for the. Pathophysiology and diagnosis of multiple myeloma jatin shah, md, explains that there is no clear reason for why patients develop multiple myeloma, and so theres no clear risk factor.
Multiple myeloma is a type of cancer that affects plasma cells. Imwg criteria for the diagnosis of myeloma and guidelines for. The median survival of the disease has doubled as a result of several new active. A clarification to imwg criteria for coding cr and vgpr in patients in whom the only measurable. Multiple myeloma often is seen in the veteran population, and va providers should be familiar with its diagnosis and treatment so that an. Beside the one in the multiple myeloma diagnostic calculator above, there is the international myeloma working group diagnostic criteria. Multiple myeloma mm is a disease that is primarily treated by hematologists. Multiple myeloma affects slightly more men than women. Production of monoclonal protein by myeloma cells the characteristic property of myeloma cells is the production and secretion release of monoclonal protein into the blood andor urine.
In hospital you are likely to have xrays taken of your arms, legs, skull, spine and pelvis to look for any damage. How i treat the young patient with multiple myeloma blood. Consensus guidelines on the diagnosis of multiple myeloma and. International myeloma working group updated criteria for the. Pdf an approach to the diagnosis and management of multiple. Multiple myeloma symptoms, diagnosis and treatment bmj. Serum monoclonal protein nonigm type, 3 gdl clonal bone marrow plasma cells. Diagnosis of multiple myeloma with stable plateau phase disease. A plasma cell tumor proven by biopsy or at least 10% plasma cells in the bone marrow and. The diagnostic workup in a patient with suspected multiple myeloma should include a complete blood count with differential. Tests to find multiple myeloma american cancer society. Group revised the diagnostic criteria for multiple myeloma. Monoclonal serum protein in 787 mayo clinic patients 1990.
The revised international myeloma working group criteria for the diagnosis of mm and related disorders are shown in table 1. International myeloma working group guidelines for the management of multiple. Diagnosis of multiple myeloma is based on the international myeloma working group guidelines table 3. The parameters include plasmacytoma on tissue biopsy, bone marrow plasmacytosis, m protein, urinary kappa or lambda excretion, marrow plasmacytosis, lytic bone lesions, evidence of a monoclonal protein, and hypoglobulinemia of normal proteins. The most common clinical diagnosis was monoclonal gammopathy of undetermined significance mgus, which occurred in 63% of patients fig. International myeloma working group imwg uniform response criteria for multiple myeloma 1 the international myeloma working group established the below criteria in order to. It is recommended to use the terminology of multiple myeloma and.
Multiple myeloma mm is a plasma cell pc malignancy of terminally differentiated b. The diagnostic criteria for smoldering asymptomatic multiple myeloma is a serum m protein level of 3 g per dl 30 g per l or more, 10 percent or more bone marrow plasma cells, and no related organ or tis sue impairment i. When patients with myeloma have disease outside the bone marrow, this is called extramedullary disease emd. Test findings such as cancer cells in the bone marrow, abnormal proteins in the blood, low levels of red blood cells, imaging scans that show tumors, and kidney dysfunction are evidence that doctors use to diagnose myeloma and related disorders. Diagnostic criteria of multiple myeloma sciencedirect.
Imwg consensus perspectives risk factors for progression and guidelines for monitoring and management, establishes criteria for mgus that is at low, intermediate, and high risk of progression to myeloma. Myeloma associated al amyloidosis is reported in 1230% of multiple myeloma patients. Theses recommendations are excerpted from palumbo a et. International myeloma working group diagnostic criteria for multiple myeloma and related plasma cell disorders disorder disease definition nonigm mgus all three criteria must be met. Updated diagnostic criteria and staging system for multiple. Diagnosis the revised international myeloma working group criteria for the diagnosis of multiple myeloma and related disorders are shown on table i 1. Multiple myeloma stages survival rates by stage for multiple myeloma. Multiple myeloma accounts for approximately 10% of hematologic malignancies.
Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Multiple myeloma can present with a wide constellation of symptoms including hypercalcaemia, anaemia, renal impairment andor bony pain. The diagnostic criteria for multiple myeloma are based on the results of diagnostic tests done on specimens of blood, urine, bone, and bone marrow. Updated criteria for the diagnosis of multiple myeloma managing. Dexamethasone in patients pts with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant asct. Smoldering multiple myeloma smm higher level of disease than mgus. Criteria for a multiple myeloma diagnosis a physician can make a multiple myeloma diagnosis based on a physical exam, a patients symptoms, and findings from lab work, biopsies, and imaging studies. Consensus recommendations for standard investigative workup. Multiple myeloma mm is a plasma cell dyscrasia characterized by terminally differentiated plasma cells, infiltration of the bone marrow by plasma cells, and the presence of a monoclonal immunoglobulin or immunoglobulin fragment in the serum. New criteria for diagnosing multiple myeloma mayo clinic. International myeloma working group imwg updated the diagnostic criteria for mm to add. In germany there are around 6500 new cases of multiple myeloma each year and it is the third most commonly occurring disease of the blood after leukemia and nonhodgkin lymphoma.
130 1139 217 636 1132 418 1356 717 420 842 503 413 86 152 520 1323 1482 1036 659 1002 814 1148 124 981 613 19 861 528 431 640 226 560 595 828 31 512 345 189 126 1364 253 893